Association of patients' highest GPF levels with outcomes
| Outcome (n) . | Median GPF level ± SE (mg/dL) . | P value (Wilcoxon) . |
|---|---|---|
| Oxygen use | .35 | |
| No oxygen (31) | 86 ± 11 | |
| Oxygen (21) | 112 ± 9.37 | |
| Ventilator use | .0097 | |
| No ventilator (38) | 85 ± 7.1 | |
| Ventilator (14) | 131 ± 17 | |
| ECMO use | .046 | |
| No ECMO (45) | 89 ± 7.5 | |
| ECMO (7) | 142 ± 23 | |
| ARDS diagnosis | .0010 | |
| No ARDS (34) | 79 ± 7.5 | |
| ARDS (18) | 131 ± 13 | |
| ICU status | .014 | |
| No ICU (29) | 112 ± 9.8 | |
| ICU (23) | 57 ± 10 | |
| VTE incidence | .64 | |
| No VTE (46) | 97 ± 7.9 | |
| VTE (6) | 116 ± 21 | |
| Death | .013 | |
| Lived (41) | 86 ± 7.3 | |
| Died (11) | 130 ± 18 |
| Outcome (n) . | Median GPF level ± SE (mg/dL) . | P value (Wilcoxon) . |
|---|---|---|
| Oxygen use | .35 | |
| No oxygen (31) | 86 ± 11 | |
| Oxygen (21) | 112 ± 9.37 | |
| Ventilator use | .0097 | |
| No ventilator (38) | 85 ± 7.1 | |
| Ventilator (14) | 131 ± 17 | |
| ECMO use | .046 | |
| No ECMO (45) | 89 ± 7.5 | |
| ECMO (7) | 142 ± 23 | |
| ARDS diagnosis | .0010 | |
| No ARDS (34) | 79 ± 7.5 | |
| ARDS (18) | 131 ± 13 | |
| ICU status | .014 | |
| No ICU (29) | 112 ± 9.8 | |
| ICU (23) | 57 ± 10 | |
| VTE incidence | .64 | |
| No VTE (46) | 97 ± 7.9 | |
| VTE (6) | 116 ± 21 | |
| Death | .013 | |
| Lived (41) | 86 ± 7.3 | |
| Died (11) | 130 ± 18 |
SE, standard error.